ACE and cancer: However, our findings for genetically proxied ACE inhibition are in agreement with those from short-term randomized controlled trials for these site-specific cancers and suggest that long-term use of these drugs may not influence cancer risk, though we cannot rule out small effects from their long-term use [3].